首页> 美国卫生研究院文献>British Medical Journal >Coagulation and Fibrinolytic Systems in Pre-eclampsia and Eclampsia
【2h】

Coagulation and Fibrinolytic Systems in Pre-eclampsia and Eclampsia

机译:子痫前期和子痫的凝血和纤溶系统

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The coagulation and fibrinolytic mechanisms were investigated in a group of patients with severe pre-eclampsia and eclampsia and the findings were compared with those of healthy women in late pregnancy. In patients with pre-eclampsia the following significant differences were found: (1) greater depression of plasma fibrinolytic activity (euglobulin lysis time) than in normal pregnancy, (2) a higher level of inhibitor to urokinaseinduced lysis, (3) increased levels of serum fibrin degradation products, and (4) reduced platelet counts.In patients with eclampsia a progressive increase of the level of serum fibrin degradation products was found over the three days following eclamptic seizures. No such increase occurred after grand mal seizures in late pregnancy. The findings in this study support the view that intravascular clotting is taking place in pre-eclampsia and that this disturbance of the balance between coagulation and fibrinolysis may be localized to certain areas of the vascular compartment, particularly the placental and renal circulations. Fibrin deposition in the maternal vessels supplying the placenta would impair the placental blood flow, which may explain the placental insufficiency which occurs in pre-eclampsia. Likewise fibrin deposition in the renal vasculature will result in glomerular damage and proteinuria. Hypertension may be related to the renal ischaemic changes or a compensatory response to the presence of fibrin deposition in the vascular compartment. This evidence of intravascular fibrin deposition raises the question of the possible therapeutic value of antithrombotic agents to inhibit the clotting process. On a theoretical basis such treatment might be expected to improve blood flow to the placenta and thereby fetal growth.
机译:对一组患有重度先兆子痫和子痫的患者的凝血和纤溶机制进行了研究,并将其发现与妊娠晚期健康女性的结果进行了比较。在先兆子痫患者中发现以下显着差异:(1)血浆纤溶活性的降低(正常球蛋白溶解时间)比正常妊娠大;(2)尿激酶诱导的溶解抑制剂水平更高;(3)子痫发作后的三天内,发现子痫患者血清纤维蛋白降解产物水平逐渐升高,并且(4)血小板计数降低。妊娠晚期大发作后没有发生这种增加。这项研究的发现支持以下观点:子痫前期发生血管内凝血,凝血和纤维蛋白溶解之间平衡的这种紊乱可能局限于血管腔的某些区域,尤其是胎盘和肾循环。纤维蛋白沉积在供应胎盘的产妇血管中会损害胎盘血流量,这可能解释了先兆子痫中发生的胎盘功能不全。同样地,纤维蛋白在肾血管中的沉积将导致肾小球损伤和蛋白尿。高血压可能与肾脏缺血变化或对血管腔内纤维蛋白沉积的代偿性反应有关。血管内纤维蛋白沉积的这一证据提出了抗血栓药抑制凝血过程可能具有治疗价值的问题。从理论上讲,这种治疗有望改善流向胎盘的血液,从而改善胎儿的生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号